Old Web
English
Sign In
Acemap
>
Paper
>
Eliglustat for Gaucher disease Type 1 (GD1): Safety results from a Phase 2 study after 2 years of treatment
Eliglustat for Gaucher disease Type 1 (GD1): Safety results from a Phase 2 study after 2 years of treatment
2011
M. Judith Peterschmitt
Elena Lukina
Nora Watman
Marta Dragosky
Marcelo Iastrebner
Gregory M. Pastores
Elsa Avila Arreguin
Hanna Rosenbaum
Mici Phillips
Mathilde Kaper
Dominique Bertin-Millet
Ana Cristina Puga
Keywords:
Eliglustat
Phases of clinical research
Disease
Biology
Genetics
Diabetes mellitus
Pediatrics
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]